Select for export SAT-219 Hepatic 5-HT2B receptor antagonism mediates the anti-steatotic and antifibrotic effects of psilocybin in preclinical MASH models Details DOI 10.1016/s0168-8278(26)01861-1 Copy citation Copy BibTeX Journal of Hepatology 2026-04-30 Anna Signor, Martina Colognesi, Giovanna Finzi, Daniela Gabbia, Andrea Mattarei, Stefano Comai OpenAlex Published psilocybin Chronic PainPharmacologyReceptor Pharmacology Animal Study Antagonism More
Select for export FRI-407 Adding the serotonergic agonist psilocybin to semaglutide as a novel combination therapy to cure MASLD Details DOI 10.1016/s0168-8278(25)01632-0 Copy citation Copy BibTeX Journal of Hepatology 2025-04-30 Martina Colognesi, Daniela Gabbia, Anna Signor, Stefano Comai, Andrea Mattarei, Gianfranco Pasut OpenAlex Published psilocybin PharmacologyReceptor Pharmacology Other Psilocybin More
Select for export THU-285 Lownonpsychedelic dosed of psilocybin for the therapy of MASLD Details DOI 10.1016/s0168-8278(24)01739-2 Copy citation Copy BibTeX Journal of Hepatology 2024-05-31 Martina Colognesi, Daniela Gabbia, Andrea Rinaldi, Luciano Cascione, Ilaria Zanotto, Stefano Comai OpenAlex Published psilocybin Pharmacology Other Psilocybin More
Select for export WED-123 Female mice with cirrhosis are more prone to acute and chronic effects of psilocybin exposure without tolerance compared to male mice Details DOI 10.1016/s0168-8278(24)00826-2 Copy citation Copy BibTeX Journal of Hepatology 2024-05-31 Jessica L. Maltman, Derrick Zhao, Alaina M. Jaster, Yunling Tai, Jing Zeng, Javier Maeso-Gonzalez OpenAlex Published psilocybin PharmacologyAnimal Study Animal Study Psilocybin More